name,category,terms1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),INTERPRO[450001881$IPR002123:Phospholipid/glycerol acyltransferase, 450004045$IPR004552:1-acyl-sn-glycerol-3-phosphate acyltransferase]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),KEGG_PATHWAY[470038775$hsa00561:Glycerolipid metabolism, 470038778$hsa00564:Glycerophospholipid metabolism, 470038779$hsa00565:Ether lipid metabolism]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),OMIM_DISEASE[520000551$Berardinelli-Seip congenital lipodystrophy, 520002904$Lipodystrophy, congenital generalized, type 1]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),PIR_SUPERFAMILY[630012579$PIRSF015813:1-acyl-sn-glycerol-3-phosphate acyltransferase]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),SMART[760000502$SM00563:PlsC]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790000362$congenital generalized lipodystrophy, 790000430$diabetes mellitus, 790000446$disease mutation, 790000919$membrane, 790001156$phospholipid biosynthesis, 790001162$phosphoprotein, 790001547$transferase, 790001555$transmembrane]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),UP_SEQ_FEATURE[850000732$chain:1-acyl-sn-glycerol-3-phosphate acyltransferase beta, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117491$short sequence motif:HXXXXD motif, 850118574$splice variant, 850118623$transmembrane region]
CCAAT/enhancer binding protein (C/EBP), beta,BIOCARTA[30000160$h_il6Pathway:IL 6 signaling pathway]
CCAAT/enhancer binding protein (C/EBP), beta,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper, 450014789$IPR016468:CCAAT/enhancer-binding]
CCAAT/enhancer binding protein (C/EBP), beta,PIR_SUPERFAMILY[630005805$PIRSF005879:CCAAT/enhancer-binding, 630005806$PIRSF005879:CCAAT/enhancer-binding protein]
CCAAT/enhancer binding protein (C/EBP), beta,SMART[760000306$SM00338:BRLZ]
CCAAT/enhancer binding protein (C/EBP), beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000356$complete proteome, 790000434$differentiation, 790000449$DNA binding, 790000466$dna-binding, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001592$ubl conjugation]
CCAAT/enhancer binding protein (C/EBP), beta,UP_SEQ_FEATURE[850010080$chain:CCAAT/enhancer-binding protein beta, 850102580$compositionally biased region:Poly-Pro, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850105852$helix, 850106258$modified residue, 850114423$region of interest:Required for Lys-174 sumoylation, 850117294$sequence conflict, 850117295$sequence variant, 850118624$turn]
D-dopachrome tautomerase-like,INTERPRO[450001243$IPR001398:Macrophage migration inhibitory factor, 450018060$IPR019829:Macrophage migration inhibitory factor, conserved site]
D-dopachrome tautomerase-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000891$lyase]
D-dopachrome tautomerase-like,UP_SEQ_FEATURE[850014208$chain:D-dopachrome decarboxylase-like protein, 850106258$modified residue]
F-box and leucine-rich repeat protein 16,SP_PIR_KEYWORDS[790000356$complete proteome, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 16,UP_SEQ_FEATURE[850018790$chain:F-box/LRR-repeat protein 16, 850102586$compositionally biased region:Pro-rich, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850117295$sequence variant]
G protein-coupled receptor kinase 4,BIOCARTA[30000007$h_agpcrPathway:Attenuation of GPCR Signaling]
G protein-coupled receptor kinase 4,INTERPRO[450000207$IPR000239:GPCR kinase, 450000294$IPR000342:Regulator of G protein signalling, 450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
G protein-coupled receptor kinase 4,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038841$hsa04144:Endocytosis]
G protein-coupled receptor kinase 4,SMART[760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000285$SM00315:RGS]
G protein-coupled receptor kinase 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000881$lipoprotein, 790001063$nucleotide-binding, 790001100$palmitate, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
G protein-coupled receptor kinase 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850020253$chain:G protein-coupled receptor kinase 4, 850103028$domain:AGC-kinase C-terminal, 850105086$domain:Protein kinase, 850105178$domain:RGS, 850106263$nucleotide phosphate-binding region:ATP, 850113517$region of interest:N-terminal, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
RAB GTPase activating protein 1,INTERPRO[450000166$IPR000195:RabGAP/TBC, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
RAB GTPase activating protein 1,PIR_SUPERFAMILY[630029978$PIRSF038444:Rab1-like GAP]
RAB GTPase activating protein 1,SMART[760000143$SM00164:TBC, 760000407$SM00462:PTB]
RAB GTPase activating protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000640$GTPase activation, 790001162$phosphoprotein]
RAB GTPase activating protein 1,UP_SEQ_FEATURE[850056511$chain:Rab GTPase-activating protein 1, 850104993$domain:PID, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850118574$splice variant]
RCAN family member 3,INTERPRO[450006329$IPR006931:Calcipressin]
RCAN family member 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
RCAN family member 3,UP_SEQ_FEATURE[850008914$chain:Calcipressin-3, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
SH2 domain containing 5,INTERPRO[450000852$IPR000980:SH2 motif, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
SH2 domain containing 5,SMART[760000224$SM00252:SH2, 760000407$SM00462:PTB]
SH2 domain containing 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001397$SH2 domain]
SH2 domain containing 5,UP_SEQ_FEATURE[850060516$chain:SH2 domain-containing protein 5, 850105346$domain:SH2, 850106258$modified residue]
SH2 domain protein 2A,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain protein 2A,KEGG_PATHWAY[470038852$hsa04370:VEGF signaling pathway]
SH2 domain protein 2A,SMART[760000224$SM00252:SH2]
SH2 domain protein 2A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000081$angiogenesis, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain, 790001399$sh3-binding]
SH2 domain protein 2A,UP_SEQ_FEATURE[850060511$chain:SH2 domain-containing protein 2A, 850102586$compositionally biased region:Pro-rich, 850105346$domain:SH2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant]
SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae),INTERPRO[450010814$IPR011989:Armadillo-like helical]
SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae),OMIM_DISEASE[520003079$Marinesco-Sjogren syndrome]
SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001212$polymorphism, 790001266$protein transport, 790001405$signal, 790001554$translocation, 790001558$transport]
SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae),UP_SEQ_FEATURE[850035331$chain:Nucleotide exchange factor SIL1, 850105770$glycosylation site:N-linked (GlcNAc...), 850112426$region of interest:Interaction with HSPA5 and localization to the endoplasmic reticulum, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
SMYD family member 5,INTERPRO[450001068$IPR001214:SET, 450002557$IPR002893:Zinc finger, MYND-type]
SMYD family member 5,SMART[760000286$SM00317:SET]
SMYD family member 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
SMYD family member 5,UP_SEQ_FEATURE[850060448$chain:SET and MYND domain-containing protein 5, 850102507$compositionally biased region:Glu-rich, 850102572$compositionally biased region:Poly-Glu, 850105340$domain:SET, 850117294$sequence conflict, 850118853$zinc finger region:MYND-type]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,INTERPRO[450001485$IPR001675:Glycosyl transferase, family 29, 450010937$IPR012163:Sialyltransferase]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,PIR_SUPERFAMILY[630005480$PIRSF005557:sialyltransferase, 630005481$PIRSF005557:Sialyl_trans]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,UP_SEQ_FEATURE[850067358$chain:Type 2 lactosamine alpha-2,3- sialyltransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
anthrax toxin receptor 2,INTERPRO[450001802$IPR002035:von Willebrand factor, type A, 450007676$IPR008399:Anthrax toxin receptor, C-terminal, 450007677$IPR008400:Anthrax toxin receptor, extracellular, 450015684$IPR017360:Anthrax toxin receptor 2]
anthrax toxin receptor 2,OMIM_DISEASE[520001905$Fibromatosis, juvenile hyaline, 520002392$Hyalinosis, infantile systemic]
anthrax toxin receptor 2,PIR_SUPERFAMILY[630029605$PIRSF038023:anthrax toxin receptor, 630029606$PIRSF038023:Anthrax_toxin_receptor_2]
anthrax toxin receptor 2,SMART[760000296$SM00327:VWA]
anthrax toxin receptor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
anthrax toxin receptor 2,UP_SEQ_FEATURE[850005535$chain:Anthrax toxin receptor 2, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850102883$disulfide bond, 850105627$domain:VWFA, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105986$metal ion-binding site:Divalent metal cation, 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
asparaginase like 1,INTERPRO[450000214$IPR000246:Peptidase T2, asparaginase 2]
asparaginase like 1,PIR_SUPERFAMILY[630006231$PIRSF006297:YbiK protein]
asparaginase like 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase]
asparaginase like 1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850027707$chain:L-asparaginase, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038832$hsa04070:Phosphatidylinositol signaling system, 470038835$hsa04114:Oocyte meiosis, 470038845$hsa04270:Vascular smooth muscle contraction, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038879$hsa04740:Olfactory transduction, 470038882$hsa04910:Insulin signaling pathway, 470038883$hsa04912:GnRH signaling pathway, 470038885$hsa04916:Melanogenesis, 470038891$hsa05010:Alzheimer's disease, 470038904$hsa05214:Glioma]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),PIR_SUPERFAMILY[630002469$PIRSF002350:calmodulin]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),SMART[760000046$SM00054:EFh]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000473$duplication, 790000480$EF hand, 790000811$isopeptide bond, 790000825$kinase, 790000950$methylated amino acid, 790000953$methylation, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850000630$calcium-binding region:4, 850009122$chain:Calmodulin, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
chromosome 6 open reading frame 221,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 6 open reading frame 221,UP_SEQ_FEATURE[850017813$chain:ES cell-associated transcript 1 protein, 850104536$domain:KH; atypical, 850117295$sequence variant]
cortistatin; apoptosis-inducing, TAF9-like domain 1,INTERPRO[450016435$IPR018142:Somatostatin/Cortistatin, C-terminal]
cortistatin; apoptosis-inducing, TAF9-like domain 1,PIR_SUPERFAMILY[630001951$PIRSF001814:somatostatin]
cortistatin; apoptosis-inducing, TAF9-like domain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000276$centromere, 790000315$chromosomal protein, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000708$hormone, 790001065$nucleus, 790001363$Secreted, 790001405$signal]
cortistatin; apoptosis-inducing, TAF9-like domain 1,UP_SEQ_FEATURE[850010673$chain:Centromere protein S, 850102883$disulfide bond, 850107247$peptide:Cortistatin-17, 850107248$peptide:Cortistatin-29, 850117814$signal peptide, 850118574$splice variant]
dynactin 4 (p62),INTERPRO[450007864$IPR008603:Dynactin p62]
dynactin 4 (p62),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 4 (p62),SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
dynactin 4 (p62),UP_SEQ_FEATURE[850016481$chain:Dynactin subunit 4, 850106258$modified residue, 850117295$sequence variant]
interleukin 27 receptor, alpha,INTERPRO[450003096$IPR003529:Long hematopoietin receptor, gp130 family 2, conserved site, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
interleukin 27 receptor, alpha,SMART[760000051$SM00060:FN3]
interleukin 27 receptor, alpha,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
interleukin 27 receptor, alpha,UP_SEQ_FEATURE[850026569$chain:Interleukin-27 receptor subunit alpha, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117329$short sequence motif:Box 1 motif, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
kelch-like 18 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006066$IPR006651:Kelch, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
kelch-like 18 (Drosophila),PIR_SUPERFAMILY[630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
kelch-like 18 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 18 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000819$kelch repeat, 790001304$repeat]
kelch-like 18 (Drosophila),UP_SEQ_FEATURE[850027133$chain:Kelch-like protein 18, 850103083$domain:BACK, 850103177$domain:BTB, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850118574$splice variant]
mannosidase, endo-alpha-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000624$golgi apparatus, 790000743$hydrolase, 790000919$membrane, 790001409$Signal-anchor, 790001555$transmembrane]
mannosidase, endo-alpha-like,UP_SEQ_FEATURE[850022104$chain:Glycoprotein endo-alpha-1,2-mannosidase- like protein, 850102566$compositionally biased region:Poly-Arg, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
perforin 1 (pore forming protein),BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000079$h_d4gdiPathway:D4-GDI Signaling Pathway, 30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway]
perforin 1 (pore forming protein),INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001647$IPR001862:Membrane attack complex component/perforin/complement C9, 450011699$IPR013032:EGF-like region, conserved site, 450016334$IPR018029:C2 membrane targeting protein]
perforin 1 (pore forming protein),KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038888$hsa04940:Type I diabetes mellitus, 470038915$hsa05320:Autoimmune thyroid disease, 470038917$hsa05330:Allograft rejection, 470038918$hsa05332:Graft-versus-host disease, 470038923$hsa05416:Viral myocarditis]
perforin 1 (pore forming protein),OMIM_DISEASE[520002272$Hemophagocytic lymphohistiocytosis, familial, 2, 520002991$Lymphoma, non-Hodgkin]
perforin 1 (pore forming protein),SMART[760000211$SM00239:C2, 760000402$SM00457:MACPF]
perforin 1 (pore forming protein),SP_PIR_KEYWORDS[790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000406$cytolysis, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000539$Familial hemophagocytic lymphohistiocytosis, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
perforin 1 (pore forming protein),UP_SEQ_FEATURE[850037708$chain:Perforin-1, 850102883$disulfide bond, 850103199$domain:C2, 850103596$domain:EGF-like, 850104738$domain:MACPF, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118273$site:Important for oligomerization, 850118623$transmembrane region]
regulator of G-protein signaling 9,INTERPRO[450000294$IPR000342:Regulator of G protein signalling, 450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014319$IPR015898:G-protein, gamma-like subunit]
regulator of G-protein signaling 9,OMIM_DISEASE[520000668$Bradyopsia]
regulator of G-protein signaling 9,PIR_SUPERFAMILY[630028460$PIRSF036966:regulator of G protein signaling, RGS7 type]
regulator of G-protein signaling 9,SMART[760000041$SM00049:DEP, 760000196$SM00224:GGL, 760000285$SM00315:RGS]
regulator of G-protein signaling 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001377$sensory transduction, 790001408$Signal transduction inhibitor, 790001546$transducer, 790001622$vision]
regulator of G-protein signaling 9,UP_SEQ_FEATURE[850057041$chain:Regulator of G-protein signaling 9, 850103515$domain:DEP, 850104021$domain:G protein gamma, 850105178$domain:RGS, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
regulatory associated protein of MTOR, complex 1,COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
regulatory associated protein of MTOR, complex 1,INTERPRO[450000307$IPR000357:HEAT, 450001490$IPR001680:WD40 repeat, 450003598$IPR004083:Regulatory associated protein of TOR, 450010814$IPR011989:Armadillo-like helical, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup]
regulatory associated protein of MTOR, complex 1,KEGG_PATHWAY[470038842$hsa04150:mTOR signaling pathway, 470038882$hsa04910:Insulin signaling pathway]
regulatory associated protein of MTOR, complex 1,SMART[760000289$SM00320:WD40]
regulatory associated protein of MTOR, complex 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
regulatory associated protein of MTOR, complex 1,UP_SEQ_FEATURE[850057151$chain:Regulatory-associated protein of mTOR, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850118574$splice variant]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G,INTERPRO[450001441$IPR001627:Semaphorin/CD100 antigen, 450003160$IPR003599:Immunoglobulin subtype, 450003205$IPR003659:Plexin/semaphorin/integrin, 450006486$IPR007110:Immunoglobulin-like, 450014355$IPR015943:WD40/YVTN repeat-like]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G,PIR_SUPERFAMILY[630005453$PIRSF005526:semaphorin]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G,SMART[760000357$SM00409:IG, 760000369$SM00423:PSI, 760000545$SM00630:Sema]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790001162$phosphoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G,UP_SEQ_FEATURE[850059298$chain:Semaphorin-3G, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105337$domain:Sema, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide]
small G protein signaling modulator 3,INTERPRO[450000166$IPR000195:RabGAP/TBC, 450001294$IPR001452:Src homology-3 domain, 450003532$IPR004012:RUN]
small G protein signaling modulator 3,SMART[760000143$SM00164:TBC, 760000295$SM00326:SH3, 760000527$SM00593:RUN]
small G protein signaling modulator 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000631$growth arrest, 790001212$polymorphism, 790001398$sh3 domain]
small G protein signaling modulator 3,UP_SEQ_FEATURE[850060997$chain:Small G protein signaling modulator 3, 850105135$domain:Rab-GAP TBC, 850105223$domain:RUN, 850105350$domain:SH3, 850117295$sequence variant, 850118574$splice variant]
sorting nexin 32,INTERPRO[450001492$IPR001683:Phox-like, 450013150$IPR014637:Sorting nexin, Snx5/Snx6 types, 450013846$IPR015404:Vps5 C-terminal]
sorting nexin 32,PIR_SUPERFAMILY[630028403$PIRSF036924:Snx5_Snx6, 630028404$PIRSF036924:sorting nexin, Snx5/Snx6 types]
sorting nexin 32,SMART[760000282$SM00312:PX]
sorting nexin 32,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
sorting nexin 32,UP_SEQ_FEATURE[850061558$chain:Sorting nexin-32, 850105129$domain:PX, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
transcription factor 7 (T-cell specific, HMG-box),INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2, 450012182$IPR013558:CTNNB1 binding, N-teminal]
transcription factor 7 (T-cell specific, HMG-box),KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038856$hsa04520:Adherens junction, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038903$hsa05213:Endometrial cancer, 470038905$hsa05215:Prostate cancer, 470038906$hsa05216:Thyroid cancer, 470038907$hsa05217:Basal cell carcinoma, 470038911$hsa05221:Acute myeloid leukemia, 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC)]
transcription factor 7 (T-cell specific, HMG-box),SMART[760000349$SM00398:HMG]
transcription factor 7 (T-cell specific, HMG-box),SP_PIR_KEYWORDS[790000020$activator, 790000052$alternative promoter usage, 790000053$alternative splicing, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001642$wnt signaling pathway]
transcription factor 7 (T-cell specific, HMG-box),UP_SEQ_FEATURE[850064988$chain:Transcription factor 7, 850102920$DNA-binding region:HMG box, 850111365$region of interest:CTNNB1-binding, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
tumor necrosis factor receptor superfamily, member 10a,BIOCARTA[30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ]
tumor necrosis factor receptor superfamily, member 10a,INTERPRO[450000415$IPR000488:Death, 450001212$IPR001368:TNFR/CD27/30/40/95 cysteine-rich region, 450010009$IPR011029:DEATH-like, 450015624$IPR017301:TNF-related apoptosis-inducing ligand receptor]
tumor necrosis factor receptor superfamily, member 10a,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038843$hsa04210:Apoptosis, 470038868$hsa04650:Natural killer cell mediated cytotoxicity]
tumor necrosis factor receptor superfamily, member 10a,PIR_SUPERFAMILY[630029436$PIRSF037867:CD261_antigen, 630029437$PIRSF037867:TNF-related apoptosis-inducing ligand receptor]
tumor necrosis factor receptor superfamily, member 10a,SMART[760000004$SM00005:DEATH, 760000181$SM00208:TNFR]
tumor necrosis factor receptor superfamily, member 10a,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
tumor necrosis factor receptor superfamily, member 10a,UP_SEQ_FEATURE[850067190$chain:Tumor necrosis factor receptor superfamily member 10A, 850102565$compositionally biased region:Poly-Ala, 850102883$disulfide bond, 850103507$domain:Death, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117108$repeat:TNFR-Cys 1, 850117109$repeat:TNFR-Cys 2, 850117111$repeat:TNFR-Cys 3, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ubiquitin family domain containing 1,INTERPRO[450000534$IPR000626:Ubiquitin, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
ubiquitin family domain containing 1,SMART[760000186$SM00213:UBQ]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),OMIM_DISEASE[520003206$Mental retardation, X-linked syndromic]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),PIR_SUPERFAMILY[630001738$PIRSF001567:ubiquitin-protein ligase E2]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000859$ligase, 790001063$nucleotide-binding, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068077$chain:Ubiquitin-conjugating enzyme E2 A, 850117294$sequence conflict]
vanin 3,INTERPRO[450002644$IPR003010:Nitrilase/cyanide hydratase and apolipoprotein N-acyltransferase, 450010895$IPR012101:Biotinidase, eukaryotic]
vanin 3,PIR_SUPERFAMILY[630010108$PIRSF011861:Biotinidase]
vanin 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000628$gpi-anchor, 790000743$hydrolase, 790000881$lipoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal]
vanin 3,UP_SEQ_FEATURE[850100080$chain:Vascular non-inflammatory molecule 3, 850103370$domain:CN hydrolase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105861$lipid moiety-binding region:GPI-anchor amidated serine, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
